Highlights
NASDAQ: CTIC       Cti Biopharm Corp
Last Price Today's Change   Day's Range   Trading Volume
1.03   -0.02 (1.90%)  1.01 - 1.07  212,100

Overview

 
Avg Volume (4 weeks):253,505
4 Weeks Range:0.96 - 1.19
4 Weeks Price Volatility (%):
30.43%
52 Weeks Range:0.62 - 1.93
52 Weeks Price Volatility (%):
31.30%
Average Price Target: 3.00
Price Target Upside/Downside: +1.97

Headlines



No recent Headlines for this stock.


Business Background

CTI Biopharma Corp is a biopharmaceutical company focused on the development and commercialization of less toxic, more effective cancer therapies. The company's therapeutic area is blood-related cancers. One of the company's products, Pixantrone (PIXUVRI), received conditional marketing approval in the EU in 2012 to treat refractory aggressive B-cell non-Hodgkin lymphoma. Another product is Pacritinib, an oral tyrosine kinase inhibitor to treat mutations such as Janus associated kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3).

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3684  4518  456  189 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 2.13+0.74 
 SHIP 0.13-0.011 
 HTZ 0.555-2.285 
 GE 6.80+0.39 
 BAC 24.28+1.62 
 XLF 23.06+1.14 
 AAL 11.14+1.44 
 SPY 299.08+3.64 
 UAL 29.54+4.14 
 MARK 2.87+0.61 
Partners & Brokers